TCL Archive Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate April 25, 2014
TCL Archive DCBDC Bard Approves Expansion Of SPORE Program To GY Cancers; Okays Two other RFAs December 4, 1992
TCL Archive Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee November 16, 1979
TCL Archive NIH Seeks Method For Allocating Research Funds, Determine Economic Impact By Disease Category April 26, 1974
TCL Archive In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid March 14, 1986
